Pain Therapeutics

Venue: Crowne Plaza - The City

Location: London, United Kingdom

Event Date/Time: Jun 07, 2010 End Date/Time: Jun 08, 2010
Early Registration Date: Mar 31, 2010
Report as Spam


This event will look at a wide range of issues within the pain therapeutics arena. It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of biomarkers and the cannabinoid approach.

Attend this conference and:

• Hear from some of the most important and influential experts working in pain therapeutics
• Learn about the challenges of early drug development
• Study the latest targets and compounds being researched
• Network with people you need to know in the pain therapeutics world
This year’s keynote addresses will include:
• Chas Bountra, Chief Scientist, Structural Genomics Consortium, University of Oxford
• Linda Surh, Director, Drug Discovery Global Regulatory Affairs, GlaxoSmithKline
• José Miguel Vela, Basic Research & Drug Discovery, Esteve
• Sharon Bingham, In Vivo Pharmacology & Translational Science, GlaxoSmithKline
• Jane Hughes, Associate Director, Neuroscience, Medimmune
• Steve England, Associate Research Fellow, Pfizer
• Lars Arendt-Nielsen, Director, Centre for Sensory-Motor Interaction, Aalborg University

PLUS associated post conference workshop

Translation from Model to Man and Back in association with AstraZeneca
9th June 2010, Crowne Plaza - The City

This workshop will address the gap between discovery and development and the translational tools used to bridge that gap.